Principal Investigator
Zelia Correa
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231407
Clinical Trial Summary
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Eye Cancer
Contact Information
Phone Number
305-243-2647